In Phase 2 in pancreatic cancer (TEDOPaM, sponsor GERCOR) in monotherapy and in combination with checkpoint inhibitor Opdivo ®. CoVepiT: a prophylactic vaccine against COVID-19, developed using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback